Free Trial

Taysha Gene Therapies (TSHA) Institutional Ownership

Taysha Gene Therapies logo
$2.58 +0.17 (+7.05%)
Closing price 04:00 PM Eastern
Extended Trading
$2.56 -0.02 (-0.74%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Taysha Gene Therapies (NASDAQ:TSHA)

Current
Institutional Ownership
Percentage
77.70%
Number of
Institutional Buyers
(last 12 months)
57
Total
Institutional Inflows
(last 12 months)
$86.79M
Number of
Institutional Sellers
(last 12 months)
24
Total
Institutional Outflows
(last 12 months)
$68.84M
Get TSHA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Taysha Gene Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TSHA Institutional Buying and Selling by Quarter

Taysha Gene Therapies Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/8/2025 Rhumbline Advisers205,462$286K0.0%+7.0%0.100%
3/24/2025Wellington Management Group LLP585,594$1.01M0.0%+26.4%0.286%
2/17/2025VR Adviser LLC3,225,180$5.58M0.4%-64.2%1.574%
2/17/2025Squarepoint Ops LLC211,842$366K0.0%+105.4%0.103%
2/17/2025RTW Investments LP8,672,630$15.00M0.2%-42.0%4.232%
2/17/2025Rafferty Asset Management LLC252,257$436K0.0%N/A0.123%
2/17/2025Polar Capital Holdings Plc3,000,000$5.19M0.0%-0.8%1.464%
2/17/2025ProShare Advisors LLC59,076$102K0.0%+32.3%0.029%
2/17/2025Nuveen Asset Management LLC546,414$945K0.0%-3.6%0.267%
2/17/2025Octagon Capital Advisors LP10,450,000$18.08M3.0%+128.6%5.099%
2/17/2025Millennium Management LLC151,614$262K0.0%N/A0.074%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.108,604$188K0.0%+23.3%0.053%
2/17/2025Granahan Investment Management LLC1,636,381$2.83M0.1%+43.6%0.798%
2/17/2025Ground Swell Capital LLC14,660$25K0.0%N/A0.007%
2/17/2025First Manhattan CO. LLC.28,500$49K0.0%N/A0.014%
2/17/2025Deutsche Bank AG151,083$261K0.0%-94.1%0.074%
2/17/2025DAFNA Capital Management LLC522,500$904K0.2%N/A0.255%
2/17/2025Bank of America Corp DE1,710,303$2.96M0.0%+1,178.9%0.835%
2/17/2025BNP Paribas Financial Markets23,644$41K0.0%N/A0.012%
2/17/2025Ameriprise Financial Inc.22,993$40K0.0%N/A0.011%
2/17/2025Acuta Capital Partners LLC884,244$1.53M1.5%-58.3%0.431%
2/14/2025Jane Street Group LLC169,575$293K0.0%+57.6%0.083%
2/14/2025Northern Trust Corp1,458,732$2.52M0.0%+6.3%0.712%
2/14/2025Aquatic Capital Management LLC78,246$135K0.0%N/A0.038%
2/14/2025Virtus ETF Advisers LLC31,597$55K0.0%+43.0%0.015%
2/14/2025Adage Capital Partners GP L.L.C.5,000,000$8.65M0.0%N/A2.440%
2/14/2025Hsbc Holdings PLC20,391$36K0.0%+65.6%0.010%
2/14/2025Avoro Capital Advisors LLC19,999,999$34.60M0.5%+7.2%9.759%
2/14/2025B Group Inc.965,556$1.67M1.0%N/A0.471%
2/14/2025Tower Research Capital LLC TRC 51,085$88K0.0%+268.8%0.025%
2/14/2025MetLife Investment Management LLC62,990$109K0.0%-17.2%0.031%
2/13/2025Marshall Wace LLP138,111$239K0.0%-71.6%0.067%
2/13/2025Mariner LLC58,342$101K0.0%+337.5%0.028%
2/13/2025Barclays PLC335,238$587K0.0%+35.6%0.164%
2/13/2025Renaissance Technologies LLC878,448$1.52M0.0%N/A0.429%
2/13/2025ADAR1 Capital Management LLC177,707$307K0.1%-29.3%0.087%
2/13/2025Wells Fargo & Company MN103,384$179K0.0%+43.7%0.050%
2/12/2025Geode Capital Management LLC3,572,349$6.18M0.0%+0.3%1.743%
2/12/2025Wellington Management Group LLP585,594$1.01M0.0%+26.4%0.286%
2/12/2025Norges Bank1,461,120$2.53M0.0%N/A0.713%
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
2/12/2025JPMorgan Chase & Co.2,643,755$4.57M0.0%-11.9%1.290%
2/11/2025EntryPoint Capital LLC61,495$106K0.0%+127.5%0.030%
2/11/2025Vanguard Group Inc.8,906,764$15.41M0.0%+7.8%4.346%
2/11/2025LPL Financial LLC60,000$104K0.0%N/A0.029%
2/11/2025AXQ Capital LP22,432$39K0.0%N/A0.011%
2/11/2025Virtu Financial LLC107,544$186K0.0%N/A0.052%
2/11/2025Privium Fund Management B.V.134,900$233K0.1%+12.4%0.066%
2/10/2025Cibc World Markets Corp16,405$28K0.0%N/A0.008%
2/10/2025Commonwealth Equity Services LLC59,069$102K0.0%+110.4%0.029%
2/7/2025E Fund Management Co. Ltd.17,844$31K0.0%N/A0.009%
2/6/2025Charles Schwab Investment Management Inc.474,257$820K0.0%+2.5%0.231%
2/4/2025Los Angeles Capital Management LLC137,460$238K0.0%-33.6%0.067%
2/4/2025 Bank of New York Mellon Corp450,261$779K0.0%+33.1%0.220%
1/30/2025Quantum Private Wealth LLC794,976$1.38M0.4%+3.6%0.388%
1/17/2025 SG Americas Securities LLC28,498$49K0.0%-55.5%0.014%
12/26/2024JPMorgan Chase & Co.3,001,397$6.03M0.0%+1.3%1.465%
12/19/2024 Principal Financial Group Inc.15,799$32K0.0%-26.9%0.008%
11/27/2024Franklin Resources Inc.100,795$201K0.0%N/A0.049%
11/19/2024Barclays PLC247,280$513K0.0%+356.0%0.121%
11/16/2024Geode Capital Management LLC3,562,758$7.16M0.0%+23.7%1.738%
11/15/2024Barclays PLC247,280$513K0.0%+356.0%0.121%
11/15/2024Jane Street Group LLC107,572$216K0.0%-16.0%0.052%
11/15/2024Wellington Management Group LLP463,192$931K0.0%N/A0.226%
11/15/2024State Street Corp3,469,068$6.97M0.0%+4.5%1.693%
11/15/2024RTW Investments LP14,946,420$30.04M0.4%-20.5%7.293%
11/14/2024Acuta Capital Partners LLC2,118,992$4.26M3.4%-9.1%1.034%
11/14/2024MetLife Investment Management LLC76,037$153K0.0%+81.9%0.037%
11/13/2024FMR LLC18,678,527$37.54M0.0%-11.9%9.114%
11/13/2024The Manufacturers Life Insurance Company60,665$122K0.0%-54.5%0.030%
11/12/2024Charles Schwab Investment Management Inc.462,867$930K0.0%+7.7%0.226%
11/9/2024Intech Investment Management LLC42,094$85K0.0%N/A0.021%
11/5/2024GSA Capital Partners LLP233,560$469K0.0%+64.7%0.114%
11/4/2024Los Angeles Capital Management LLC206,992$416K0.0%N/A0.101%
11/2/2024Privium Fund Management B.V.120,000$241K0.1%+21.8%0.059%
11/1/2024Quantum Private Wealth LLC767,616$1.54M0.5%+5.1%0.375%
10/25/2024 China Universal Asset Management Co. Ltd.39,417$79K0.0%+79.4%0.019%
10/11/2024Creative Planning14,118$28K0.0%N/A0.007%
10/3/2024 SG Americas Securities LLC63,984$129K0.0%N/A0.034%
8/15/2024Scientech Research LLC43,350$97K0.0%N/A0.023%
8/15/2024The Manufacturers Life Insurance Company133,213$298K0.0%+109.0%0.071%
8/14/2024Squarepoint Ops LLC80,255$180K0.0%-62.5%0.043%
8/14/2024Marshall Wace LLP786,094$1.76M0.0%-23.7%0.420%
8/12/2024Marathon Trading Investment Management LLC45,340$102K0.0%-79.7%0.024%
8/9/2024Renaissance Technologies LLC41,100$92K0.0%-87.5%0.022%
8/1/2024 Rhumbline Advisers184,284$413K0.0%N/A0.099%
8/1/2024Privium Fund Management B.V.98,500$213K0.1%N/A0.053%
7/29/2024 Principal Financial Group Inc.21,609$48K0.0%N/A0.012%
7/26/2024 Bank of New York Mellon Corp454,464$1.02M0.0%N/A0.243%
7/17/2024Quantum Private Wealth LLC730,520$1.64M0.6%+4.6%0.391%
5/17/2024RA Capital Management L.P.10,872,503$31.20M0.4%-41.1%5.814%
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
5/17/2024Artal Group S.A.3,687,548$10.58M0.3%+0.7%1.972%
5/15/2024Price T Rowe Associates Inc. MD1,099,329$3.16M0.0%-10.4%0.588%
5/15/2024Avoro Capital Advisors LLC18,650,000$53.53M0.6%+328.2%9.972%
5/14/2024EntryPoint Capital LLC122,905$353K0.3%-57.9%0.066%
5/14/2024StemPoint Capital LP1,087,785$3.12M0.8%N/A0.582%
5/10/2024Acadian Asset Management LLC26,477$75K0.0%-94.2%0.014%
5/10/2024Vanguard Group Inc.5,917,414$16.98M0.0%-4.5%3.164%
5/7/2024Quantum Private Wealth LLC698,520$2.01M0.7%+9.2%0.374%
4/29/2024 China Universal Asset Management Co. Ltd.35,908$103K0.0%+66.1%0.019%
4/17/2024 Cannon Global Investment Management LLC24,200$69K0.2%N/A0.013%
(Data available from 1/1/2016 forward)

TSHA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TSHA shares?

During the previous two years, 87 institutional investors and hedge funds held shares of Taysha Gene Therapies. The most heavily invested institutionals were FMR LLC ($37.54M), Avoro Capital Advisors LLC ($34.60M), RA Capital Management L.P. ($31.20M), Octagon Capital Advisors LP ($18.08M), Vanguard Group Inc. ($15.41M), RTW Investments LP ($15.00M), and Artal Group S.A. ($10.58M).Learn more on TSHA's institutional investors.

What percentage of Taysha Gene Therapies stock is owned by institutional investors?

77.70% of Taysha Gene Therapies stock is owned by institutional investors. Learn more on TSHA's institutional investor holdings.

Which institutional investors have been buying Taysha Gene Therapies stock?

Of the 79 institutional investors that purchased Taysha Gene Therapies stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($23.38M), RA Capital Management L.P. ($18.47M), RTW Investments LP ($16.89M), Avoro Capital Advisors LLC ($16.07M), Adage Capital Partners GP L.L.C. ($6.50M), Octagon Capital Advisors LP ($5.88M), and Vanguard Group Inc. ($4.38M).

How much institutional buying is happening at Taysha Gene Therapies?

Institutional investors have bought a total of 116,618,171 shares in the last 24 months. This purchase volume represents approximately $328.61M in transactions.

Which Taysha Gene Therapies major shareholders have been selling company stock?

Of the 25 institutional investors that sold Taysha Gene Therapies stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($10.13M), RA Capital Management L.P. ($7.60M), VR Adviser LLC ($5.77M), FMR LLC ($2.53M), Deutsche Bank AG ($2.41M), Acuta Capital Partners LLC ($1.45M), and Acadian Asset Management LLC ($768.09K).

How much institutional selling is happening at Taysha Gene Therapies?

Institutional investors have sold a total of 33,139,327 shares in the last 24 months. This volume of shares sold represents approximately $69.07M in transactions.



This page (NASDAQ:TSHA) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners